Back to mobile site

BofA Securities Downgrades Galera Therapeutics (GRTX) to Underperform

May 27, 2022 7:56 AM EDT Send to a Friend
BofA Securities analyst Tazeen Ahmad downgraded Galera Therapeutics (NASDAQ: GRTX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login